BHST - BioHarvest Sciences Annual Revenue Growth (Last Twelve Months)

BioHarvest Sciences (BHST) possesses a unique bio-cellular component synthesis system that creates a long-term competitive advantage. Current trailing 12-month revenue dynamics confirm this potential, where the 4.90 metric determines this level. Despite a reliance on external capital due to its early stage of monetization, the firm is firmly establishing its status as a leading scientific developer in the eyes of consumers.
Summary analytical data breakdowns for BioHarvest Sciences Inc. (BHST)

This indicator calculates the percentage change in aggregate revenue over the last twelve months relative to the same period last year, capturing the daily dynamics of consumer demand. The YoY sales growth trajectory over the rolling period reflects the commercial efficiency of BioHarvest Sciences (BHST) proprietary cell extraction, confirming the company's market dominance in the pharmacological bioreactor segment through the lens of actual cash flows.